KCND3 Gene Spinocerebellar Ataxia Type 22 Autosomal Dominant NGS Genetic DNA Test
Introduction
The KCND3 Gene Spinocerebellar Ataxia Type 22 Autosomal Dominant NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with Spinocerebellar Ataxia Type 22 (SCA22), a neurological disorder. This test utilizes Next-Generation Sequencing (NGS) technology to provide accurate and comprehensive results, enabling healthcare professionals to assess the risk of developing this condition.
What the Test Measures
This genetic test specifically measures mutations in the KCND3 gene, which have been linked to the development of SCA22. By analyzing the genetic material, the test can determine if an individual carries the genetic markers that increase the likelihood of developing this disorder.
Who Should Consider This Test
Individuals with a family history of neurological disorders, particularly those showing symptoms of ataxia, should consider this test. Symptoms may include:
- Loss of coordination and balance
- Difficulty walking
- Speech difficulties
- Hand tremors
Risk factors include a family history of SCA22 or other related genetic disorders.
Benefits of Taking the Test
Taking the KCND3 Gene Spinocerebellar Ataxia Type 22 test offers several benefits:
- Early identification of genetic predisposition to SCA22
- Informed decision-making regarding lifestyle and health management
- Potential for early intervention and treatment options
- Access to genetic counseling for affected family members
Understanding Your Results
Results from the KCND3 Gene test will indicate whether mutations are present. Positive results suggest a higher risk of developing SCA22, while negative results may provide reassurance. It is crucial to discuss results with a healthcare provider to understand implications and next steps.
Test Name and Price
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| KCND3 Gene Spinocerebellar Ataxia Type 22 Autosomal Dominant NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
To schedule your KCND3 Gene Spinocerebellar Ataxia Type 22 Autosomal Dominant NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with any inquiries and guide you through the testing process.
Turnaround time for results is approximately 3 to 4 weeks, and samples can be collected through blood or extracted DNA. Prior to testing, a genetic counseling session is recommended to discuss family history and draw a pedigree chart.
Trust DNA Labs Nigeria for your genetic testing needs and take the first step towards understanding your health!
